Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.1M Buy
1,727,639
+147,827
+9% +$8.49M 0.41% 71
2026
Q1
$87.9M Buy
1,579,812
+78,712
+5% +$5.09M 0.44% 66
2025
Q4
$93.8M Buy
1,501,100
+43,509
+3% +$2.59M 0.47% 59
2025
Q3
$84.2M Buy
1,457,591
+339,959
+30% +$18.2M 0.42% 66
2025
Q2
$55M Buy
1,117,632
+108,828
+11% +$5M 0.28% 83
2025
Q1
$44.6M Buy
1,008,804
+266,655
+36% +$13.3M 0.23% 89
2024
Q4
$34.9M Buy
742,149
+488,602
+193% +$23.5M 0.18% 92
2024
Q3
$11.9M Buy
+253,547
New +$10.7M 0.06% 130

Other funds holding GIL

Bahl & Gaynor's GIL Position: Q2 2026 in Review

Bahl & Gaynor increased its Gildan (GIL) stake by 9.4% in Q2 2026, buying an estimated $8.49M and bringing the position to 1,727,639 shares worth $89.1M. The position accounts for 0.41% of the portfolio, ranked #71.

Bahl & Gaynor first reported a position in GIL in Q3 2024 and has held it in 8 quarters since. The position peaked at $93.8M in Q4 2025. 461 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

  • Bahl & Gaynor held 1,727,639 shares of Gildan worth $89.1M as of Q2 2026.
  • Bahl & Gaynor bought 147,827 Gildan shares in Q2 2026, an estimated $8.49M.
  • Gildan made up 0.41% of Bahl & Gaynor's portfolio in Q2 2026, its #71 holding.
  • Bahl & Gaynor first reported a position in Gildan in Q3 2024 and has held it in 8 quarters since.
  • Bahl & Gaynor's Gildan position peaked at $93.8M in Q4 2025.
  • 461 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.